Literature DB >> 27099588

Hepatocellular Carcinoma: Current Questions and Future Directions.

Robert G Gish1.   

Abstract

Entities:  

Year:  2015        PMID： 27099588      PMCID： PMC4836587     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  12 in total

1.  Determinants of serum alpha-fetoprotein levels in hepatitis C-infected patients.

Authors:  Peter Richardson; Zhigang Duan; Jennifer Kramer; Jessica A Davila; Gia L Tyson; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2011-12-07       Impact factor: 11.382

2.  Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.

Authors:  Riad Salem; Robert J Lewandowski; Laura Kulik; Edward Wang; Ahsun Riaz; Robert K Ryu; Kent T Sato; Ramona Gupta; Paul Nikolaidis; Frank H Miller; Vahid Yaghmai; Saad M Ibrahim; Seanthan Senthilnathan; Talia Baker; Vanessa L Gates; Bassel Atassi; Steven Newman; Khairuddin Memon; Richard Chen; Robert L Vogelzang; Albert A Nemcek; Scott A Resnick; Howard B Chrisman; James Carr; Reed A Omary; Michael Abecassis; Al B Benson; Mary F Mulcahy
Journal:  Gastroenterology       Date:  2010-10-30       Impact factor: 22.682

Review 3.  Hepatocellular carcinoma tumour markers: current role and expectations.

Authors:  Nicole Rich; Amit G Singal
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-08-22       Impact factor: 3.043

Review 4.  Targeted systemic therapies for hepatocellular carcinoma: clinical perspectives, challenges and implications.

Authors:  Catherine Frenette; Robert Gish
Journal:  World J Gastroenterol       Date:  2012-02-14       Impact factor: 5.742

5.  New agents on the horizon in hepatocellular carcinoma.

Authors:  Andrew X Zhu
Journal:  Ther Adv Med Oncol       Date:  2013-01       Impact factor: 8.168

6.  Systemic therapy in HCC: lessons from brivanib.

Authors:  David Bolos; Richard S Finn
Journal:  J Hepatol       Date:  2014-06-24       Impact factor: 25.083

Review 7.  Hepatocellular carcinoma: molecular and genomic guideline for the clinician.

Authors:  Catherine Frenette; Robert G Gish
Journal:  Clin Liver Dis       Date:  2011-05       Impact factor: 6.126

Review 8.  A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases.

Authors:  Akshat Saxena; Lourens Bester; Leonard Shan; Marlon Perera; Peter Gibbs; Baerbel Meteling; David L Morris
Journal:  J Cancer Res Clin Oncol       Date:  2013-12-07       Impact factor: 4.553

9.  Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography -- a randomised study.

Authors:  C Pocha; E Dieperink; K A McMaken; A Knott; P Thuras; S B Ho
Journal:  Aliment Pharmacol Ther       Date:  2013-06-10       Impact factor: 8.171

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425
View more
  2 in total

1.  Prognostic analysis of hepatocellular carcinoma on the background of liver cirrhosis via contrast-enhanced ultrasound and pathology.

Authors:  Yukai He; Fenghua Liu; Shaofeng Mou; Qingyan Li; Sikui Wang
Journal:  Oncol Lett       Date:  2018-01-12       Impact factor: 2.967

2.  Study to evaluate the immunomodulatory effects of radiofrequency ablation compared to surgical resection for liver cancer.

Authors:  Ketevan Mazmishvili; Kumar Jayant; Nona Janikashvili; Nino Kikodze; Malkhaz Mizandari; Ia Pantsulaia; Natela Paksashvili; Mikael H Sodergren; Isabella Reccia; Madhava Pai; Nagy Habib; Tinatin Chikovani
Journal:  J Cancer       Date:  2018-08-06       Impact factor: 4.207
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.